Tradestie Institutional Equity Comparison Engine

VCYT vs FATE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VCYT Overall Edge

VCYT Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Veracyte, Inc. (VCYT) driven by superior Valuation, Growth & Margin while FATE counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, VCYT trades at 15.3x Forward P/E with 15.0% operating margin (+15.1% YoY revenue) versus FATE at N/M Forward P/E and -2736.9% operating margin (+9.2% YoY). In options structure, VCYT sits in BREAKDOWN (47th %ile IV; Dealer Gamma Walls on Pro) against FATE sits in BREAKDOWN (20th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VCYT
VCYT 15.3x vs FATE N/M Fwd P/E
Growth & Margin Winner VCYT
Op Margin 15.0% vs -2736.9% ยท YoY +15.1% vs +9.2%
Momentum & Technical Winner FATE
1Y -39.8% vs +14.9% ยท 52W Pos 5% vs 8%
Options & Structure Winner FATE
BREAKDOWN (47th %ile IV) vs BREAKDOWN (20th %ile IV)
VCYT NASDAQ
Veracyte, Inc.
Services-Medical Laboratories
$24.01
-1.32% 1D
Market Cap $2.0B
1M Return -44.32%
1Y Return -39.78%
Forward P/E 15.3x
Unified AI Score
49.1 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 57.0 Mom 55.0
FATE NASDAQ
Fate Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$1.14
-10.94% 1D
Market Cap $155.7M
1M Return -36.31%
1Y Return +14.88%
Forward P/E N/M
Unified AI Score
43.0 / 100 HOLD
Tech 25.0 Fund 47.0 Flow 67.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VCYT -39.78% FATE +14.88% Spread: +54.66 pp (FATE Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period VCYT Revenue FATE Revenue VCYT Op. Margin FATE Op. Margin Margin Edge
FY2018 $90M $0M -24.2% -1415.4% VCYT
FY2019 $120M $10M -12.6% -943.1% VCYT
FY2020 $120M $30M -30.1% -407.5% VCYT
FY2021 $220M $60M -37.3% -388.6% VCYT
FY2022 $300M $100M -13.9% -320.2% VCYT
FY2023 $360M $60M -23.8% -299.9% VCYT
FY2024 $450M $10M 3.6% -1542.6% VCYT
FY2025 $520M $10M 11.2% -2222.4% VCYT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VCYT (8) vs FATE (2)
Institutional Metric VCYT FATE Criterion Row Winner
Market Capitalization Scale $2.0B $155.7M Larger Scale VCYT
Trailing P/E Ratio Valuation 15.8x N/M Lower Multiple VCYT
Forward P/E Ratio Valuation 15.3x N/M Lower Multiple VCYT
Revenue Growth (YoY) Growth +15.1% +9.2% Higher Growth VCYT
Operating Margin (TTM) Profitability 15.0% -2736.9% Higher Margin VCYT
Net Profit Margin Profitability 21.8% 0.0% Higher Margin VCYT
Return on Equity (ROE) Capital Efficiency 9.4% -67.8% Higher ROE VCYT
52-Week Range Position Momentum 5% ($22โ€“$61) 8% ($1โ€“$3) Stronger Trend FATE
Beta / 30D Volatility Risk Regime 3.01ฮฒ ยท 199% Vol 2.16ฮฒ ยท 104% Vol Lower Realized Risk FATE
Unified Institutional Score Composite Signal 49.1 / 100 (HOLD) 43.0 / 100 (HOLD) Higher Composite VCYT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VCYT vs FATE Buy Guide
VCYT BREAKDOWN
99d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 47th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live VCYT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FATE BREAKDOWN
118d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 20th %ile
IV Regime Compressed (<25th %ile)
Live FATE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VCYT nor FATE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.